Skip to content

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04783363
Acronym
SNOEZELEN
Enrollment
60
Registered
2021-03-05
Start date
2021-04-12
Completion date
2023-09-18
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Supportive care, Snoezelen

Brief summary

This is a monocentric, comparative, open-label, randomized, crossover study enrolling patients hospitalized in Strasbourg Europe Cancerology Institute, receiving repeated invasive care for cancer treatment. The purpose of this study is to compare the satisfaction of patients, regarding their perception of care, with or without Snoezelen session.

Detailed description

Patients will followed during two visits for a repeated invasive care. They will be randomized to two groups in a 1:1 ratio. Crossover plan and arms are described as follow: Arm A : Visit 1 with Snoezelen session before invasive care and Visit 2 without Snoezelen session before invasive care (standard care) Arm B : Visit 1 without Snoezelen session before invasive care (standard care) and Visit 2 with Snoezelen session before invasive care

Interventions

OTHERSnoezelen session

before one of two repeated invasive care

Sponsors

Institut de cancérologie Strasbourg Europe
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients treated for cancer and hospitalized for invasive care * Two programmed hospitalization for repeated care * Patients receiving one of the following invasive care: Huber needle application (transfusion, parenteral nutrition), complex wound dressing, intrathecal chemotherapy, ascites fluid or pleural puncture * Patients must be ≥ 18 years old * Performance Status ≤ 3 * Absence of psychiatric disorder impairing follow-up * Ability to speak, understand, write and read French * Signed informed consent from the patient * Affiliation to social security system

Exclusion criteria

* Patients presenting infectious symptoms requiring isolation * Patients \< 18 years old or patients ≥ 18 years old under supervision * Patients placed under judicial protection or guardianship * Women that are pregnant or breast-feeding

Design outcomes

Primary

MeasureTime frameDescription
Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 1immediately after invasive care at Visit 1Evaluation using a modified Visual Analog Scales, Oberts, 1984
Patient satisfaction regarding their perception of care quality (with or without Snoezelen session) at Visit 2immediately after invasive care at Visit 2Evaluation using a modified Visual Analog Scales, Oberts, 1984

Secondary

MeasureTime frameDescription
Change in patient perceived pain, with or without Snoezelen sessionAt admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2Numeric visual analog scale (0 to 10)
Change in patient perceived anxiety, with or without Snoezelen sessionAt admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°1; At admission (i.e. before Snoezelen session, if applicable) and immediately after invasive care at Visit n°2Numeric visual analog scale (0 to 10)
Comparing relationship between patient and caregiver, with or without Snoezelen sessionimmediately after invasive care at Visit 1 ; immediately after invasive care at Visit 2Numeric visual analog scale (0 to 10)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026